Doctolib — Cyborg Score 8/10

Strong
Healthcare appointment scheduling and practice management software

Strategic Profile

The company's trajectory is defined by the deep integration of agentic artificial intelligence, the pursuit of a multi-billion dollar public listing and the aggressive expansion into complex clinical and hospital ecosystems. Since late 2024 Doctolib has rolled out generative-AI features to cut documentation time; management targets reducing the 10-12 weekly hours doctors spend on paperwork. In May 2026, Doctolib acquired UK electronic patient record supplier Medicus, with the aim of bringing improved technology, AI and services to GP practices across the UK.

Cyborg Score Rationale

In fiscal year 2024, the company reported an Annual Recurring Revenue (ARR) of €348 Million, representing a 22.5% increase from the previous year. The company operates a highly sticky B2B SaaS model with 99% subscription-based revenue. While Doctolib appears on numerous 2026 IPO watchlists, no official filing has been confirmed as of the first half of the year; the company is currently engaged in discussions for a significant secondary investment, potentially led by Generation Investment Management.

Top Insights

  • The European healthcare technology landscape has reached a definitive inflection point in 2026, transitioning from a period of speculative, venture-subsidised fragmentation into a disciplined era defined by industrial maturity and strategic consolidation.
  • The Doctolib Care suite aims to replace legacy practice management systems entirely, integrating scheduling, EHR-like workflows, billing, and chronic disease management tools.
  • Doctolib is helping over 80 million patients to effectively manage their health and provide quick and easy access to optimal healthcare.
  • Doctolib plans to invest more than £100 million in the UK over the coming years, hire 150 people in London, establish a dedicated R&D centre, and bring the full power of its expertise, including its AI clinical lab, to support innovation in NHS primary care.

Named Competitors

  • DocPlanner — Healthcare appointment booking and patient engagement platform
  • Zocdoc — Doctor search and appointment booking platform
  • Practo — Healthcare search and appointment platform
  • MioDottore — Healthcare professional booking and reputation platform

Recent Developments

  • (May 2026) Acquired Medicus Health, UK electronic patient record supplier, as part of strategic expansion into NHS primary care.
  • (June 2026) Launched Doctolib Parents, an AI Health Companion for parents of children ages 0–4 with science-based content and development tracking.
  • (Q1 2026) Reported FY2024 ARR of €348M (22.5% YoY growth) and initiated secondary investment discussions expected to maintain valuation near $6.4B.

Open the full interactive Doctolib report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →